Price Alert

Galera Therapeutics Inc. (GRTX)

OTC: GRTX · Real-Time Price · USD

0.03

0.00 (9.09%)

At close: Apr 04, 2025, 2:24 PM

Galera Therapeutics Statistics

Share Statistics

Galera Therapeutics has 75.46M shares outstanding. The number of shares has increased by 38.74% in one year.

Shares Outstanding	75.46M
Shares Change (YoY)	38.74%
Shares Change (QoQ)	38.74%
Owned by Institutions (%)	0.1%
Shares Floating	31.8M
Failed to Deliver (FTD) Shares	72,275
FTD / Avg. Volume	68.5%

Short Selling Information

The latest short interest is 2.12M, so undefined% of the outstanding shares have been sold short.

Short Interest	2.12M
Short % of Shares Out	n/a
Short % of Float	5.32%
Short Ratio (days to cover)	1.16

Valuation Ratios

The PE ratio is -0.13 and the forward PE ratio is -0.04. Galera Therapeutics's PEG ratio is 0.

PE Ratio	-0.13
Forward PE	-0.04
PS Ratio	0
Forward PS	n/a
PB Ratio	-0.02
P/FCF Ratio	0
PEG Ratio	0

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Galera Therapeutics.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6, with a Debt / Equity ratio of 0.

Current Ratio	6
Quick Ratio	6
Debt / Equity	0
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	n/a
Profits Per Employee	$-2.71M
Employee Count	7
Asset Turnover	0
Inventory Turnover	n/a

Taxes

Income Tax	-203K
Effective Tax Rate	1.06%

Stock Price Statistics

The stock price has increased by -81.48% in the last 52 weeks. The beta is 2.06, so Galera Therapeutics's price volatility has been higher than the market average.

Beta	2.06
52-Week Price Change	-81.48%
50-Day Moving Average	0.04
200-Day Moving Average	0.06
Relative Strength Index (RSI)	29.87
Average Volume (20 Days)	105,505

Income Statement

Revenue	n/a
Gross Profit	-3.84M
Operating Income	-20.16M
Net Income	-18.96M
EBITDA	-20.16M
EBIT	n/a
Earnings Per Share (EPS)	-0.35

Full Income Statement

Balance Sheet

The company has 8.29M in cash and 0 in debt, giving a net cash position of 8.29M.

Cash & Cash Equivalents	8.29M
Total Debt	n/a
Net Cash	n/a
Retained Earnings	-456.36M
Total Assets	8.9M
Working Capital	7.99M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	0

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GRTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

Currently there are no analyst rating for GRTX.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	-77.23
Piotroski F-Score	3